Etilevodopa hydrochloride
CAS No. 39740-30-2
Etilevodopa hydrochloride( Etilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester )
Catalog No. M27765 CAS No. 39740-30-2
Etilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
Etilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 37 | Get Quote |
|
10MG | 59 | Get Quote |
|
25MG | 119 | Get Quote |
|
50MG | 177 | Get Quote |
|
100MG | 299 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtilevodopa hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
In VitroEtilevodopa (L-Dopa ethyl ester) hydrochloride passes unchanged through the stomach to the duodenum, where it is rapidly hydrolyzed by local esterases to Levodopa and ethanol, and is subsequently absorbed into the blood stream as Levodopa.Compared with standard Levodopa, Etilevodopa hydrochloride has greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration.
-
In Vivo
-
SynonymsEtilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester
-
PathwayOthers
-
TargetOther Targets
-
RecptornNOS/NOS1 AP
-
Research Area
-
Indication
Chemical Information
-
CAS Number39740-30-2
-
Formula Weight261.7
-
Molecular FormulaC11H16ClNO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (477.65 mM)
-
SMILESCl.CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Examorelin
Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?
-
Laurolitsine
Laurolitsine is an alkaloid isolated from the leaves of Peumus boldus Molina.
-
Lyoniside
Lyoniside and saracoside are cytotoxic to promastigotes and intracellular amastigotes, they demonstrate strong anti-leishmanial efficacies in BALB/c mice model of leishmaniasis, suggests that these two compounds potential anti-leishmanial candidates.